UNEEG Medical
Private Company
Total funding raised: $12.5M
Overview
UNEEG Medical is a commercial-stage neurotechnology company based in Denmark, focused on transforming epilepsy care through its implantable, subcutaneous EEG monitoring platform. Its CE-marked UNEEG EpiSight System captures continuous brain data for up to three years, addressing diagnostic uncertainties and enabling objective treatment assessment via proprietary AI analytics. The company is executing its European commercialization strategy and preparing for a U.S. market launch, positioning its longitudinal data as a valuable asset for clinical decision-making and pharmaceutical R&D.
Technology Platform
Implantable subcutaneous EEG (sEEG) monitoring system with external recorder, patient app, and cloud-based AI analytics software for ultra-long-term, real-world brain data collection and analysis.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
UNEEG competes with traditional inpatient video-EEG monitoring, short-term ambulatory EEG devices, and emerging wearable neuro-sensing technologies. Its primary differentiation is the multi-year, subcutaneous form factor enabling truly longitudinal data. Potential competitors include large medtech firms with neuromodulation portfolios and digital health startups focusing on seizure detection.